AE Wealth Management LLC increased its position in shares of Cameco Co. (NYSE:CCJ – Get Rating) (TSE:CCO) by 42.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 33,498 shares of the basic materials company’s stock after acquiring an additional 9,920 shares during the period. AE Wealth Management LLC’s holdings in Cameco were worth $888,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of CCJ. Capital World Investors grew its stake in Cameco by 402.0% in the 1st quarter. Capital World Investors now owns 10,131,797 shares of the basic materials company’s stock worth $295,084,000 after buying an additional 8,113,385 shares in the last quarter. FMR LLC grew its stake in Cameco by 360.1% in the 2nd quarter. FMR LLC now owns 8,186,417 shares of the basic materials company’s stock worth $172,088,000 after buying an additional 6,407,271 shares in the last quarter. Alps Advisors Inc. purchased a new position in Cameco in the 2nd quarter worth approximately $121,589,000. Mirae Asset Global Investments Co. Ltd. grew its stake in Cameco by 37.4% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,068,688 shares of the basic materials company’s stock worth $497,555,000 after buying an additional 4,644,453 shares in the last quarter. Finally, Pendal Group Ltd grew its stake in Cameco by 168.4% in the 2nd quarter. Pendal Group Ltd now owns 3,112,423 shares of the basic materials company’s stock worth $65,281,000 after buying an additional 1,952,856 shares in the last quarter. Institutional investors own 53.82% of the company’s stock.
Cameco Stock Up 0.9 %
Shares of NYSE CCJ opened at $25.62 on Friday. The company has a current ratio of 5.11, a quick ratio of 4.03 and a debt-to-equity ratio of 0.20. Cameco Co. has a 12 month low of $18.03 and a 12 month high of $32.49. The firm has a market capitalization of $11.08 billion, a PE ratio of 116.46, a price-to-earnings-growth ratio of 0.52 and a beta of 0.88. The firm has a fifty day simple moving average of $23.20 and a two-hundred day simple moving average of $24.46.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on the stock. Canaccord Genuity Group boosted their price target on shares of Cameco from C$43.00 to C$44.00 and gave the stock a “buy” rating in a research note on Wednesday, October 26th. TD Securities upped their price objective on shares of Cameco from C$40.00 to C$41.00 in a research note on Friday, October 28th. StockNews.com cut shares of Cameco from a “hold” rating to a “sell” rating in a research note on Friday, October 28th. Raymond James cut their price objective on shares of Cameco from C$45.00 to C$44.00 in a research note on Wednesday. Finally, Scotiabank cut their price objective on shares of Cameco from C$44.00 to C$42.00 in a research note on Tuesday, October 18th. One analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Cameco has an average rating of “Moderate Buy” and a consensus target price of $42.63.
Cameco Profile
Cameco Corporation produces and sells uranium. It operates through two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
See Also
- Get a free copy of the StockNews.com research report on Cameco (CCJ)
- Deere, Catepillar, PACCAR, Machinery Stocks You Need to Know
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.